Rubina Parmar

Company: Intellia Therapeutics

Job title: Vice President, Chemistry & Delivery Sciences

Seminars:

Maximizing Bioavailability of RNAi Therapies with Oligonucleotide Conjugates to Reach Previously Undruggable Therapeutic Targets 10:00 am

Whilst the hunt for next-generation delivery platforms continues, and the scope for targeting extra-hepatic tissue increases, the success of RNAi therapeutics is limited if bioavailability is not addressed. For RNAi therapies to successfully induce gene silencing, the payload must be released effectively to the target tissue. As such, this workshop will address: Utilizing machine learning…Read more

day: Pre-Conference Workshop Day